Cardiologists in NY State do not use reviews when coming up with patient referral decisions Despite nearly universal awareness of report cards on risk-altered mortality rates of specific cardiac surgeons, cardiologists in New York State usually do not use these reports when making patient referral decisions. This is actually the main bottom line of a survey evaluation led by David L. Brown, MD, Professor Medicine in the Division of Cardiovascular Medication at Stony Brook University School of Medicine . The findings are published on the web in Circulation: Cardiovascular Quality and Outcomes.

Dr Christian Homsy, CEO of Cardio3 BioSciences feedback on today’s announcement: ‘We quite definitely welcome the continued strong support of the Walloon area and this new funding from the European Commission which will help drive a number of projects within the business as we apply our technologies to address a variety of cardiac illnesses. The Walloon area has played a significant role through the history of Cardio3 BioSciences helping to provide us to the stage where our core groundbreaking technology, C-Cure, for the treating heart failing, has passed through successful completion of its Stage II clinical development stage and is likely to enter Phase III in 2012.’..